Related Experiment Video
Updated: Aug 10, 2026

Synthesis of Immunotargeted Magneto-plasmonic Nanoclusters
Published on: August 22, 2014
Immunochemical characterization of antibody-coated nanoparticles
F Velge-Roussel1, P Breton, X Guillon
1CJF INSERM 93-09, Equipe associée INRA d'Immunologie Parasitaire, UFR des Sciences Pharmaceutiques, Tours (France).
Insights
Researchers used surface plasmon resonance (SPR) to show that anti-CD4 antibody-coated nanoparticles specifically bind to CD4 molecules. This confirms their potential as targeted drug delivery systems (pharmacophores).
Area of Science:
- Biotechnology
- Nanomedicine
- Immunology
Background:
- Antibody-functionalized nanoparticles offer targeted delivery potential.
- Understanding antibody-nanoparticle interactions is crucial for developing effective nanomedicines.
Purpose of the Study:
- To characterize the specific binding of anti-CD4 antibody (IOT4a) adsorbed on poly(methylidene malonate 2.1.2) (PMM 2.1.2) nanoparticles to the CD4 molecule.
- To estimate the number of antibodies per nanoparticle and assess their accessibility.
- To evaluate the suitability of these immunonanoparticles as antibody-targeted pharmacophores.
Main Methods:
- Surface Plasmon Resonance (SPR) using BIAcore instrumentation.
- Immobilization of anti-CD4 monoclonal antibody (IOT4a) onto PMM 2.1.2 nanoparticles.
- Analysis of binding kinetics with CD4 molecules and control antibodies (rabbit anti-mouse Fc).
Main Results:
- Demonstrated specific interaction between IOT4a-PMM 2.1.2 nanoparticles and CD4 molecules.
- Molar ratio (Fc)/(Fab) of 1 indicated accessible epitopes on adsorbed antibodies.
- Estimated 2.6–3 molecules of IOT4a antibody per nanoparticle.
- Observed association rates comparable to free antibodies.
Conclusions:
- IOT4a-PMM 2.1.2 nanoparticles exhibit specific binding to CD4.
- The antibody orientation and accessibility on nanoparticles are suitable for target recognition.
- These antibody-coated nanoparticles show promise as antibody-targeted pharmacophores for drug delivery.
Abstract:
A new method using surface plasmon resonance (SPR) through the BIAcore was used to demonstrate the specific interaction between an anti-CD4 monoclonal antibody (IOT4a), adsorbed on poly(methylidene malonate 2.1.2) (PMM 2.1.2) nanoparticles, and the CD4 molecule. The results obtained were compared with the interaction of the same immunonanoparticles with rabbit anti-mouse Fc antibodies. The molar ratio (Fc)/(Fab) was 1, suggesting that the same number of epitopes on the Fc and the Fab fragments were accessible after IOT4a adsorption onto nanoparticles. Comparing the observed association rates of free antibody and antibody adsorbed on nanoparticles, the number of molecules of IOT4a antibody on PMM 2.1.2 nanoparticles was estimated as between 2.6 and 3 per nanoparticle. The properties of the antibody-coated nanoparticles are compatible with their use as antibody-targeted pharmacophores.
Related Concept Videos
Immunoprecipitation
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Immunofluorescence Microscopy
The...
Immunocytochemistry and Immunohistochemistry
These...
Immunogold Electron Microscopy

